Challenges Ahead for Independent Specialty Pharmacies

Video

Cheryl Allen, vice president of Industry Relations at Diplomat, discusses the largest challenges currently facing independent specialty pharmacies.

Cheryl Allen, vice president of Industry Relations at Diplomat, discusses the largest challenges currently facing independent specialty pharmacies.

Related Videos
Medical professional researching on a laptop while taking notes
Credit: Adobe Stock - Tierney
https://www.youtube.com/watch?v=Q-WCvWaAcC8
Yaruniv-Studio - stock.adobe.com
Technician- © pharmacytimes
Woman holding a rainbow heart for Pride Month | Image credit: Iuliia Pilipeichenko - stock.adobe.com
Related Content

Managing Burnout in the Pharmacy

September 25th 2023

Pharmacy Focus: Psychedelic Pharmacy - Ibogaine Offers Unique Benefits

September 8th 2023

Patients With Cancer Using Nonmedical Stimulants Can Continue Using Opioids, Regardless of Prognosis

September 13th 2023

Pharmacy Focus: Psychedelic Pharmacy - Managing Potential Adverse Effects With Psychedelic Medicines

May 19th 2023

Osimertinib, Chemotherapy Show Survival Benefit for Patients With Advanced, Mutated Lung Cancer

September 11th 2023

FDA Approves IND for CT7439, a Novel CDK12/13 Inhibitor to Treat Multiple Types of Advanced Solid Tumors

September 11th 2023

Managing Burnout in the Pharmacy

September 25th 2023

Pharmacy Focus: Psychedelic Pharmacy - Ibogaine Offers Unique Benefits

September 8th 2023

Patients With Cancer Using Nonmedical Stimulants Can Continue Using Opioids, Regardless of Prognosis

September 13th 2023

Pharmacy Focus: Psychedelic Pharmacy - Managing Potential Adverse Effects With Psychedelic Medicines

May 19th 2023

Osimertinib, Chemotherapy Show Survival Benefit for Patients With Advanced, Mutated Lung Cancer

September 11th 2023

FDA Approves IND for CT7439, a Novel CDK12/13 Inhibitor to Treat Multiple Types of Advanced Solid Tumors

September 11th 2023

Managing Burnout in the Pharmacy

September 25th 2023

Pharmacy Focus: Psychedelic Pharmacy - Ibogaine Offers Unique Benefits

September 8th 2023

Patients With Cancer Using Nonmedical Stimulants Can Continue Using Opioids, Regardless of Prognosis

September 13th 2023

Pharmacy Focus: Psychedelic Pharmacy - Managing Potential Adverse Effects With Psychedelic Medicines

May 19th 2023

Osimertinib, Chemotherapy Show Survival Benefit for Patients With Advanced, Mutated Lung Cancer

September 11th 2023

FDA Approves IND for CT7439, a Novel CDK12/13 Inhibitor to Treat Multiple Types of Advanced Solid Tumors

September 11th 2023
© 2023 MJH Life Sciences

All rights reserved.